# CADENCE(R) TIERED THERAPY DEFIBRILLATION SYSTEM (ABBOTT MEDICAL)

Product · id `cardio:fdaprod-p910023` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [openFDA record P910023](<https://api.fda.gov/device/pma.json?search=pma_number:P910023>), retrieved 8 November 2026. No person wrote or checked this page.

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A premarket approval (PMA) application in FDA's device records. FDA's decision code for the original application reads approved.

## Technical summary

PMA P910023. Decision 1993-04-30. Product code LWS. Device class III.

## The registry's words

- PMA number: P910023
- Trade name: CADENCE(R) TIERED THERAPY DEFIBRILLATION SYSTEM
- Generic name: Implantable cardioverter defibrillator (non-CRT)
- Applicant: ABBOTT MEDICAL
- Product code: LWS
- Advisory committee: Cardiovascular

## Claims, with the population each applies to

## Context: FDA record read by the openFDA feed

Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)

### FDA records an approval of P910023 on 1993-04-30.

- Category: Regulatory
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Limitations: Assembled by a program from openFDA; the approved or cleared uses are in FDA's own decision documents, which this record does not read. openFDA says its data is unvalidated and not for medical decisions.
- Last checked: Not recorded
- Sources:
  1. Supports: FDA premarket approval record P910023 (openFDA record) (Regulator) <https://api.fda.gov/device/pma.json?search=pma_number:P910023>
     Locator: decision\_date. Retrieved 2026-11-08T02:46:30Z. Source state: Current. Version fingerprint: 61017db8084656319123bedebcc2155b1f7465ddd084f7630be6e86c9832e75b.
     How it applies: The decision date as the record writes it.
  2. Supports: FDA premarket approval record P910023 (openFDA record) (Regulator) <https://api.fda.gov/device/pma.json?search=pma_number:P910023>
     Locator: pma\_number. Retrieved 2026-11-08T02:46:30Z. Source state: Current. Version fingerprint: 61017db8084656319123bedebcc2155b1f7465ddd084f7630be6e86c9832e75b.
     How it applies: The registry number of the record.
  3. Supports: FDA premarket approval record P910023 (openFDA record) (Regulator) <https://api.fda.gov/device/pma.json?search=pma_number:P910023>
     Locator: decision\_code. Retrieved 2026-11-08T02:46:30Z. Source state: Current. Version fingerprint: 61017db8084656319123bedebcc2155b1f7465ddd084f7630be6e86c9832e75b.
     How it applies: The decision status as the record writes it.

### FDA records an approval of panel-track supplement S006 to P910023 on 1994-10-28.

- Category: Regulatory
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Limitations: Assembled by a program from openFDA; the approved or cleared uses are in FDA's own decision documents, which this record does not read. openFDA says its data is unvalidated and not for medical decisions.
- Last checked: Not recorded
- Sources:
  1. Supports: FDA premarket approval supplement P910023/S006 (openFDA record) (Regulator) <https://api.fda.gov/device/pma.json?search=pma_number:P910023+AND+supplement_number:S006>
     Locator: decision\_date. Retrieved 2026-11-08T02:46:30Z. Source state: Current. Version fingerprint: 64fa24b79d86d8e39b9b14f8a1b0c74e0921e88392bf43b2de431c5205ed3569.
     How it applies: The decision date as the record writes it.
  2. Supports: FDA premarket approval supplement P910023/S006 (openFDA record) (Regulator) <https://api.fda.gov/device/pma.json?search=pma_number:P910023+AND+supplement_number:S006>
     Locator: supplement\_number. Retrieved 2026-11-08T02:46:30Z. Source state: Current. Version fingerprint: 64fa24b79d86d8e39b9b14f8a1b0c74e0921e88392bf43b2de431c5205ed3569.
     How it applies: The registry number of the record.
  3. Supports: FDA premarket approval supplement P910023/S006 (openFDA record) (Regulator) <https://api.fda.gov/device/pma.json?search=pma_number:P910023+AND+supplement_number:S006>
     Locator: decision\_code. Retrieved 2026-11-08T02:46:30Z. Source state: Current. Version fingerprint: 64fa24b79d86d8e39b9b14f8a1b0c74e0921e88392bf43b2de431c5205ed3569.
     How it applies: The decision status as the record writes it.

### FDA records an approval of panel-track supplement S047 to P910023 on 2000-10-27.

- Category: Regulatory
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Limitations: Assembled by a program from openFDA; the approved or cleared uses are in FDA's own decision documents, which this record does not read. openFDA says its data is unvalidated and not for medical decisions.
- Last checked: Not recorded
- Sources:
  1. Supports: FDA premarket approval supplement P910023/S047 (openFDA record) (Regulator) <https://api.fda.gov/device/pma.json?search=pma_number:P910023+AND+supplement_number:S047>
     Locator: decision\_date. Retrieved 2026-11-08T02:46:30Z. Source state: Current. Version fingerprint: 64fa24b79d86d8e39b9b14f8a1b0c74e0921e88392bf43b2de431c5205ed3569.
     How it applies: The decision date as the record writes it.
  2. Supports: FDA premarket approval supplement P910023/S047 (openFDA record) (Regulator) <https://api.fda.gov/device/pma.json?search=pma_number:P910023+AND+supplement_number:S047>
     Locator: supplement\_number. Retrieved 2026-11-08T02:46:30Z. Source state: Current. Version fingerprint: 64fa24b79d86d8e39b9b14f8a1b0c74e0921e88392bf43b2de431c5205ed3569.
     How it applies: The registry number of the record.
  3. Supports: FDA premarket approval supplement P910023/S047 (openFDA record) (Regulator) <https://api.fda.gov/device/pma.json?search=pma_number:P910023+AND+supplement_number:S047>
     Locator: decision\_code. Retrieved 2026-11-08T02:46:30Z. Source state: Current. Version fingerprint: 64fa24b79d86d8e39b9b14f8a1b0c74e0921e88392bf43b2de431c5205ed3569.
     How it applies: The decision status as the record writes it.

## Guidance, authorization and access

### Regulatory decision `cardio:fdadec-p910023-approval`

- Product: CADENCE(R) TIERED THERAPY DEFIBRILLATION SYSTEM (ABBOTT MEDICAL) (`cardio:fdaprod-p910023`)
- Authority: U.S. Food and Drug Administration (`core:fda`)
- Decision: Approval, 1993-04-30
- Product version: Original application
- Pathway: PMA
- Submission: P910023
- Product code: LWS
- Device class: III
- Indication: Not stated in the openFDA record
- Jurisdictions: United States
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Basis: claim `cardio:fdaclaim-p910023-approval`

### Regulatory decision `cardio:fdadec-p910023-s006-supplement`

- Product: CADENCE(R) TIERED THERAPY DEFIBRILLATION SYSTEM (ABBOTT MEDICAL) (`cardio:fdaprod-p910023`)
- Authority: U.S. Food and Drug Administration (`core:fda`)
- Decision: Supplemental approval, 1994-10-28
- Product version: Panel-track supplement S006
- Pathway: PMA
- Submission: P910023/S006
- Product code: LWS
- Device class: III
- Indication: Not stated in the openFDA record
- Jurisdictions: United States
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Basis: claim `cardio:fdaclaim-p910023-s006-supplement`

### Regulatory decision `cardio:fdadec-p910023-s047-supplement`

- Product: CADENCE(R) TIERED THERAPY DEFIBRILLATION SYSTEM (ABBOTT MEDICAL) (`cardio:fdaprod-p910023`)
- Authority: U.S. Food and Drug Administration (`core:fda`)
- Decision: Supplemental approval, 2000-10-27
- Product version: Panel-track supplement S047
- Pathway: PMA
- Submission: P910023/S047
- Product code: LWS
- Device class: III
- Indication: Not stated in the openFDA record
- Jurisdictions: United States
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Basis: claim `cardio:fdaclaim-p910023-s047-supplement`

## Connected pages

- Registry product code files this product under this technology: Implantable cardioverter-defibrillator (ICD) (`cardio:implantable-cardioverter-defibrillator`)

## Provenance

Content hash: c810459ce0bd3265a56d770395e4f5ee34233d1be97aeb697e88e879199c85b1
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
